HEALTHSTORY 1053· JULY 4, 2026

Roche Drug Sets New Standard for KRAS-Driven Lung Cancer

A Roche drug has established a new treatment standard for KRAS-driven lung cancer, STAT+ reported, marking a significant moment in an oncology target that has long resisted effective therapy. The news lands as the broader biotech sector's…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 1052FBI Director Kash Patel Filed Late Disclosure on Strategy Stock, Reports Say NEXT STORY 1054 →North Island Credit Union Collects School Backpacks for San Diego Youth Through Boys & Girls Clubs Partnership

Keep reading

More from the desk.

14HEALTH

Congress opposes White House plan for NIH grant review board

The short version is that federal lawmakers are pushing back against a proposal to place political appointees in charge of approving scientific research funding. This plan would create a commission with the power to sign off on every grant…

health2 MIN

26HEALTH

Lilly breast cancer combination receives regulatory approval

The short version is that Eli Lilly and Company secured approval for a breast cancer treatment combination. In plain terms, a drug combination is a therapeutic strategy that pairs two distinct agents to treat a disease, often aiming to…

health2 MIN

38HEALTH

Radiopharma giants merge in $1.65 billion deal after FDA rejection

Two leading radiopharmaceutical companies are merging in a transaction valued at at least $1.65 billion. This move follows a surprise FDA rejection for one of the firms. In plain terms, radiopharmaceuticals are medicines that deliver…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk